These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 23745702)

  • 1. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGRP receptor antagonism and migraine.
    Edvinsson L; Ho TW
    Neurotherapeutics; 2010 Apr; 7(2):164-75. PubMed ID: 20430315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
    Villalón CM; Olesen J
    Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP receptors in the control of pain and inflammation.
    Benemei S; Nicoletti P; Capone JG; Geppetti P
    Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CGRP antagonists: novel concept for treatment of migraine].
    Nieber K
    Med Monatsschr Pharm; 2009 May; 32(5):182-5. PubMed ID: 19469188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
    Messlinger K; Fischer MJ; Lennerz JK
    Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
    ter Haar E; Koth CM; Abdul-Manan N; Swenson L; Coll JT; Lippke JA; Lepre CA; Garcia-Guzman M; Moore JM
    Structure; 2010 Sep; 18(9):1083-93. PubMed ID: 20826335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.
    Eftekhari S; Edvinsson L
    Ther Adv Neurol Disord; 2010 Nov; 3(6):369-78. PubMed ID: 21179597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
    Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
    Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level.
    Eftekhari S; Edvinsson L
    BMC Neurosci; 2011 Nov; 12():112. PubMed ID: 22074408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP antagonists: unravelling the role of CGRP in migraine.
    Doods H; Arndt K; Rudolf K; Just S
    Trends Pharmacol Sci; 2007 Nov; 28(11):580-7. PubMed ID: 17963849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
    Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
    Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
    Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
    J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP receptor antagonists: a new choice for acute treatment of migraine?
    Durham PL
    Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus.
    Sixt ML; Messlinger K; Fischer MJ
    Brain; 2009 Nov; 132(Pt 11):3134-41. PubMed ID: 19737844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
    Yuan H; White CS; Silberstein SD
    Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
    Tepper SJ; Stillman MJ
    Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.